Resultados de la búsqueda 21-30 of 7530 for Drug

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't approved by the U.S. Food and Drug Administration (FDA). However ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

9. Radiología - Ensayos clínicos - Mayo Clinic

   The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S.

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...